Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Advanced Solid Tumor 1Advanced Pancreatic Cancer 1

Interventions

Gemcitabine 4Taxes 3S 1 (combination) 3130-nm albumin-bound paclitaxel 3toripalimab 2Drug Therapy 2Albumin-Bound Paclitaxel 2surufatinib 1nimotuzumab 1envafolimab 1endostar protein 1conteltinib 1camrelizumab 1apatinib 1Simvastatin 1Radiosurgery 1Nivolumab 1Metformin 1Immunotherapy 1Endostatins 1Digoxin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Advanced Pancreatic Cancer × conteltinib × Clear all
NCT05580445 2023-11-22

Safety, Pharmacokinetics and Efficacy of CT-707, Toripalimab and Gemcitabine in Advanced Pancreatic Cancer

Shouyao Holdings (Beijing) Co. LTD

Phase 1/2 Unknown
114 enrolled
Gastrointestinal

Advanced Pancreatic Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡